Certara, Inc. (NASDAQ:CERT) Short Interest Up 18.7% in January

Certara, Inc. (NASDAQ:CERT - Get Free Report) was the recipient of a significant increase in short interest in January. As of January 31st, there was short interest totalling 5,260,000 shares, an increase of 18.7% from the January 15th total of 4,430,000 shares. Based on an average daily volume of 1,260,000 shares, the days-to-cover ratio is presently 4.2 days. Approximately 4.7% of the company's stock are sold short.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on CERT shares. Barclays cut their price objective on Certara from $14.00 to $12.00 and set an "equal weight" rating for the company in a report on Thursday, November 7th. Robert W. Baird lowered their price objective on shares of Certara from $18.00 to $13.00 and set a "neutral" rating on the stock in a research note on Tuesday, November 5th. Six investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $15.92.

Certara Stock Performance

Shares of CERT stock remained flat at $14.03 during midday trading on Wednesday. 1,651,549 shares of the company traded hands, compared to its average volume of 1,266,628. Certara has a 1-year low of $9.41 and a 1-year high of $19.87. The stock has a market cap of $2.26 billion, a price-to-earnings ratio of -70.15, a P/E/G ratio of 9.73 and a beta of 1.57. The firm has a 50 day moving average price of $12.25 and a 200 day moving average price of $11.66. The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 0.28.

Institutional Investors Weigh In On Certara

A number of institutional investors have recently made changes to their positions in the company. Venturi Wealth Management LLC lifted its holdings in Certara by 839.1% during the 4th quarter. Venturi Wealth Management LLC now owns 2,808 shares of the company's stock worth $30,000 after purchasing an additional 2,509 shares during the last quarter. Wells Fargo & Company MN lifted its holdings in shares of Certara by 48.4% during the fourth quarter. Wells Fargo & Company MN now owns 3,208 shares of the company's stock worth $34,000 after buying an additional 1,047 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Certara by 112.3% in the third quarter. Blue Trust Inc. now owns 3,925 shares of the company's stock valued at $46,000 after acquiring an additional 2,076 shares during the period. Johnson Financial Group Inc. acquired a new position in shares of Certara in the fourth quarter valued at about $47,000. Finally, KBC Group NV increased its position in Certara by 48.2% during the third quarter. KBC Group NV now owns 4,873 shares of the company's stock worth $57,000 after acquiring an additional 1,584 shares during the period. Institutional investors own 73.96% of the company's stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.